FDA Approves Baricitinib for Rheumatoid Arthritis FDA Approves Baricitinib for Rheumatoid Arthritis

The FDA has approved baricitinib 2-mg tablets for the treatment of moderately to severely active rheumatoid arthritis in adults, but declined to approve the 4-mg tablets.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news